Puma Biotechnology EBITDA per Share 2011-2026 | PBYI

Annual EBITDA per Share Puma Biotechnology

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
0.96	0.87	0.94	0.75	0.31	-0.51	-0.77	-2.3	-7.79	-8.27	-7.46	-4.72	-1.9	-3.41	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.96	-8.27	-2.38

Quarterly EBITDA per Share Puma Biotechnology

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-0.02	0.19	0.14	0.14	-	0.45	-0.04	0.01	-	0.18	0.11	0.16	-	0.06	0.27	0.04	-	-0.02	-0.41	0.57	-	-0.13	0.29	-0.31	-	-0.21	-0.56	0.31	-	-0.16	-1.01	-0.58	-	-2.04	-2.1	-1.97	-	-2.01	-2.03	-2.19	-	-1.86	-2.01	-1.66	-	-1.18	-1.28	-0.67	-	-0.49	-0.44	-0.41	-	-1.29	-0.73	-0.59	-	-0.08	-0.01	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
0.57	-2.19	-0.568

EBITDA per Share of other stocks in the Biotechnology industry

Issuer	EBITDA per Share	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-0.71	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	-15.2	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	-0.82	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	-2.35	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	0.08	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	-2.46	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	6.75	-	-	$ 40.3 B	USA
Genfit SA GNFT	-2.24	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-0.03	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	-0.87	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	-0.09	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	12.6	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	0.79	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	2.22	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-23.7	-	-	$ 269 M	USA
Coherus BioSciences CHRS	-1.54	$ 1.38	-3.17 %	$ 162 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	-3.51	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	-0.04	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	-0.03	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-0.03	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	-0.54	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	-7.17	$ 50.22	-2.45 %	$ 4.52 B	Schweiz
Институт стволовых клеток человека ISKJ	-2.69	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-2.84	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-1.81	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-1.29	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	-4.28	$ 29.5	-0.34 %	$ 1.96 B	USA
Generation Bio Co. GBIO	-2.06	-	-	$ 344 M	USA
IMV IMV	-0.28	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	-4.25	-	-	$ 3.67 B	USA
Akouos AKUS	-2.45	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	-2.42	-	-	$ 7.46 M	Israel
Enlivex Therapeutics Ltd. ENLV	-0.32	$ 0.7	0.91 %	$ 32 M	Israel
Esperion Therapeutics ESPR	0.29	$ 3.15	0.32 %	$ 655 M	USA
Cyclacel Pharmaceuticals CYCCP	-3.85	-	-4.36 %	$ 27 M	USA
Eton Pharmaceuticals ETON	0.12	$ 31.66	3.7 %	$ 852 M	USA
Freeline Therapeutics Holdings plc FRLN	-1.63	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	-1.67	-	-	$ 3.37 B	China
Exelixis EXEL	3.32	$ 53.51	0.98 %	$ 14.5 B	USA
Anika Therapeutics ANIK	-0.4	$ 14.94	2.54 %	$ 214 M	USA
Advaxis ADXS	-5.96	-	-9.65 %	$ 45.9 M	USA
Forte Biosciences FBRX	-5.45	$ 17.03	0.18 %	$ 221 M	USA
Aeterna Zentaris AEZS	-3.37	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	-6.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-0.36	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-3.89	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	-6.03	$ 2.97	0.38 %	$ 4.89 M	Israel
Aptose Biosciences APTO	0.01	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-0.92	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	-6.41	-	-0.23 %	$ 916 M	USA